Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.62
CAH's Cash to Debt is ranked higher than
69% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.47 vs. CAH: 0.62 )
CAH' s 10-Year Cash to Debt Range
Min: 0.01   Max: 1.29
Current: 0.62

0.01
1.29
Equity to Asset 0.24
CAH's Equity to Asset is ranked higher than
52% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. CAH: 0.24 )
CAH' s 10-Year Equity to Asset Range
Min: 0.23   Max: 0.43
Current: 0.24

0.23
0.43
Interest Coverage 14.17
CAH's Interest Coverage is ranked higher than
66% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.02 vs. CAH: 14.17 )
CAH' s 10-Year Interest Coverage Range
Min: 6.68   Max: 21.82
Current: 14.17

6.68
21.82
F-Score: 7
Z-Score: 5.06
M-Score: -2.52
WACC vs ROIC
4.59%
15.97%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 2.03
CAH's Operating margin (%) is ranked higher than
61% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.77 vs. CAH: 2.03 )
CAH' s 10-Year Operating margin (%) Range
Min: 0.99   Max: 4.15
Current: 2.03

0.99
4.15
Net-margin (%) 1.18
CAH's Net-margin (%) is ranked higher than
61% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.25 vs. CAH: 1.18 )
CAH' s 10-Year Net-margin (%) Range
Min: 0.33   Max: 2.42
Current: 1.18

0.33
2.42
ROE (%) 17.32
CAH's ROE (%) is ranked higher than
87% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.17 vs. CAH: 17.32 )
CAH' s 10-Year ROE (%) Range
Min: 5.47   Max: 28.25
Current: 17.32

5.47
28.25
ROA (%) 4.29
CAH's ROA (%) is ranked higher than
76% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.09 vs. CAH: 4.29 )
CAH' s 10-Year ROA (%) Range
Min: 1.33   Max: 11.32
Current: 4.29

1.33
11.32
ROC (Joel Greenblatt) (%) 80.82
CAH's ROC (Joel Greenblatt) (%) is ranked higher than
93% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.12 vs. CAH: 80.82 )
CAH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 19.21   Max: 73.13
Current: 80.82

19.21
73.13
Revenue Growth (3Y)(%) -3.20
CAH's Revenue Growth (3Y)(%) is ranked lower than
51% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. CAH: -3.20 )
CAH' s 10-Year Revenue Growth (3Y)(%) Range
Min: -3.2   Max: 27
Current: -3.2

-3.2
27
EBITDA Growth (3Y)(%) 9.40
CAH's EBITDA Growth (3Y)(%) is ranked higher than
69% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.10 vs. CAH: 9.40 )
CAH' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -11.7   Max: 30
Current: 9.4

-11.7
30
EPS Growth (3Y)(%) 7.10
CAH's EPS Growth (3Y)(%) is ranked higher than
61% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.30 vs. CAH: 7.10 )
CAH' s 10-Year EPS Growth (3Y)(%) Range
Min: -15.7   Max: 30.9
Current: 7.1

-15.7
30.9
» CAH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

CAH Guru Trades in Q1 2014

Louis Moore Bacon 6,078 sh (New)
Ray Dalio 48,844 sh (+90.45%)
Joel Greenblatt 379,308 sh (+47.4%)
Steven Cohen 17,553 sh (+10.67%)
Vanguard Health Care Fund 5,043,241 sh (unchged)
Jim Simons Sold Out
John Buckingham 18,131 sh (-0.74%)
Manning & Napier Advisors, Inc 18,931 sh (-2.8%)
Pioneer Investments 1,856,220 sh (-5.68%)
John Keeley 149,817 sh (-8.8%)
Caxton Associates 50,000 sh (-17.9%)
James Barrow 6,958,722 sh (-18.44%)
Paul Tudor Jones 233,468 sh (-23.25%)
Jeremy Grantham 56,000 sh (-42.5%)
RS Investment Management 418,304 sh (-50.37%)
» More
Q2 2014

CAH Guru Trades in Q2 2014

Jim Simons 123,000 sh (New)
Joel Greenblatt 680,062 sh (+79.29%)
John Buckingham 18,175 sh (+0.24%)
Caxton Associates 128,800 sh (unchged)
Louis Moore Bacon 6,078 sh (unchged)
Vanguard Health Care Fund 5,043,241 sh (unchged)
Manning & Napier Advisors, Inc Sold Out
Jeremy Grantham Sold Out
Caxton Associates Sold Out
John Keeley 145,907 sh (-2.61%)
James Barrow 6,620,964 sh (-4.85%)
RS Investment Management 372,364 sh (-10.98%)
Pioneer Investments 1,375,212 sh (-25.91%)
Ray Dalio 10,834 sh (-77.82%)
Paul Tudor Jones 9,159 sh (-96.08%)
» More
Q3 2014

CAH Guru Trades in Q3 2014

Steven Cohen 50,900 sh (New)
Paul Tudor Jones 75,000 sh (+718.87%)
John Buckingham 18,793 sh (+3.4%)
James Barrow 6,690,760 sh (+1.05%)
Pioneer Investments 2,436,448 sh (unchged)
Vanguard Health Care Fund 5,043,241 sh (unchged)
Jim Simons Sold Out
Louis Moore Bacon Sold Out
Ray Dalio Sold Out
John Keeley 144,477 sh (-0.98%)
RS Investment Management 354,064 sh (-4.91%)
Joel Greenblatt 353,619 sh (-48%)
» More
Q4 2014

CAH Guru Trades in Q4 2014

Steven Cohen 58,000 sh (+13.95%)
Pioneer Investments 2,639,786 sh (+8.35%)
James Barrow 6,744,417 sh (+0.8%)
RS Investment Management 355,279 sh (+0.34%)
Vanguard Health Care Fund 5,043,241 sh (unchged)
John Buckingham 18,396 sh (-2.11%)
John Keeley 124,297 sh (-13.97%)
Joel Greenblatt 243,387 sh (-31.17%)
Paul Tudor Jones 5,396 sh (-92.81%)
» More
» Details

Insider Trades

Latest Guru Trades with CAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-12-31 Reduce -31.17%0.08%$72.13 - $83.04 $ 88.9512%243387
Joel Greenblatt 2014-09-30 Reduce -48%0.28%$69.59 - $77.66 $ 88.9522%353619
Ray Dalio 2014-09-30 Sold Out 0.01%$69.59 - $77.66 $ 88.9522%0
Joel Greenblatt 2014-06-30 Add 79.29%0.26%$63.8 - $71.31 $ 88.9531%680062
Ray Dalio 2014-06-30 Reduce -77.82%0.02%$63.8 - $71.31 $ 88.9531%10834
James Barrow 2014-03-31 Reduce -18.44%0.15%$65.26 - $73.54 $ 88.9528%6958722
Joel Greenblatt 2014-03-31 Add 47.4%0.13%$65.26 - $73.54 $ 88.9528%379308
Ray Dalio 2014-03-31 Add 90.45%0.01%$65.26 - $73.54 $ 88.9528%48844
Vanguard Health Care Fund 2013-12-31 Reduce -39.27%0.59%$52.95 - $67.48 $ 88.9545%5043241
James Barrow 2013-12-31 Reduce -25.92%0.25%$52.95 - $67.48 $ 88.9545%8532117
Joel Greenblatt 2013-12-31 Add 78.81%0.18%$52.95 - $67.48 $ 88.9545%257325
John Keeley 2013-12-31 Add 33.23%0.05%$52.95 - $67.48 $ 88.9545%164270
Ray Dalio 2013-12-31 Reduce -65.96%0.02%$52.95 - $67.48 $ 88.9545%25646
David Dreman 2013-12-31 Sold Out 0.01%$52.95 - $67.48 $ 88.9545%0
Joel Greenblatt 2013-09-30 Add 772.85%0.21%$47.02 - $53.57 $ 88.9575%143906
David Dreman 2013-09-30 Reduce -97.55%0.13%$47.02 - $53.57 $ 88.9575%2019
John Hussman 2013-09-30 Sold Out 0.01%$47.02 - $53.57 $ 88.9575%0
Ray Dalio 2013-09-30 Add 62.57%0.01%$47.02 - $53.57 $ 88.9575%75346
Andreas Halvorsen 2013-06-30 Sold Out 0.44%$41.85 - $48.76 $ 88.9595%0
James Barrow 2013-06-30 Add 109.21%0.44%$41.85 - $48.76 $ 88.9595%10534000
Joel Greenblatt 2013-06-30 Reduce -64.59%0.06%$41.85 - $48.76 $ 88.9595%16487
Ray Dalio 2013-06-30 Reduce -68.52%0.04%$41.85 - $48.76 $ 88.9595%46346
Scott Black 2013-03-31 Sold Out 1.1%$41.18 - $47.09 $ 88.95100%0
Vanguard Health Care Fund 2013-03-31 Add 33.15%0.35%$41.18 - $47.09 $ 88.95100%8304241
Joel Greenblatt 2013-03-31 Reduce -45.69%0.09%$41.18 - $47.09 $ 88.95100%46563
James Barrow 2013-03-31 Add 25.05%0.08%$41.18 - $47.09 $ 88.95100%5035210
Ray Dalio 2013-03-31 Add 27.38%0.01%$41.18 - $47.09 $ 88.95100%147246
John Hussman 2013-03-31 Add 75%$41.18 - $47.09 $ 88.95100%4200
Andreas Halvorsen 2012-12-31 Reduce -58.66%0.82%$39.29 - $42.65 $ 88.95118%2145834
Joel Greenblatt 2012-12-31 New Buy0.2%$39.29 - $42.65 $ 88.95118%85742
Scott Black 2012-12-31 Add 18.4%0.17%$39.29 - $42.65 $ 88.95118%181008
Ray Dalio 2012-12-31 Reduce -49.74%0.06%$39.29 - $42.65 $ 88.95118%115600
John Hussman 2012-12-31 Add 100%$39.29 - $42.65 $ 88.95118%2400
Scott Black 2012-09-30 Add 43.29%0.27%$37.75 - $43.5 $ 88.95119%152883
Joel Greenblatt 2012-09-30 Sold Out 0.11%$37.75 - $43.5 $ 88.95119%0
Ray Dalio 2012-09-30 Add 104.99%0.06%$37.75 - $43.5 $ 88.95119%230000
John Hussman 2012-09-30 New Buy$37.75 - $43.5 $ 88.95119%1200
Scott Black 2012-06-30 Add 496.74%0.58%$40.42 - $43.42 $ 88.95113%106697
Joel Greenblatt 2012-06-30 Add 184.28%0.07%$40.42 - $43.42 $ 88.95113%37136
David Dreman 2012-06-30 New Buy0.07%$40.42 - $43.42 $ 88.95113%75621
Ray Dalio 2012-06-30 Add 285.57%0.05%$40.42 - $43.42 $ 88.95113%112200
Andreas Halvorsen 2012-03-31 Add 409.22%1.45%$40.82 - $43.31 $ 88.95129%5160026
John Hussman 2012-03-31 Sold Out 0.16%$40.82 - $43.31 $ 88.95129%0
Andreas Halvorsen 2011-12-31 Reduce -55.75%0.62%$39.88 - $45.49 $ 88.95112%1013317
Joel Greenblatt 2011-12-31 New Buy0.07%$39.88 - $45.49 $ 88.95112%14617
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 27.80
CAH's P/E(ttm) is ranked higher than
71% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.20 vs. CAH: 27.80 )
CAH' s 10-Year P/E(ttm) Range
Min: 6.28   Max: 73.63
Current: 27.8

6.28
73.63
Forward P/E 18.45
CAH's Forward P/E is ranked higher than
82% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.87 vs. CAH: 18.45 )
N/A
PE(NRI) 28.10
CAH's PE(NRI) is ranked higher than
71% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.40 vs. CAH: 28.10 )
CAH' s 10-Year PE(NRI) Range
Min: 6.72   Max: 74.54
Current: 28.1

6.72
74.54
P/B 4.80
CAH's P/B is ranked higher than
60% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.68 vs. CAH: 4.80 )
CAH' s 10-Year P/B Range
Min: 0.86   Max: 4.75
Current: 4.8

0.86
4.75
P/S 0.30
CAH's P/S is ranked higher than
85% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.78 vs. CAH: 0.30 )
CAH' s 10-Year P/S Range
Min: 0.08   Max: 0.39
Current: 0.3

0.08
0.39
PFCF 22.20
CAH's PFCF is ranked higher than
90% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 58.38 vs. CAH: 22.20 )
CAH' s 10-Year PFCF Range
Min: 4.13   Max: 32.08
Current: 22.2

4.13
32.08
POCF 18.77
CAH's POCF is ranked higher than
84% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.24 vs. CAH: 18.77 )
CAH' s 10-Year POCF Range
Min: 3.59   Max: 19.56
Current: 18.77

3.59
19.56
EV-to-EBIT 16.44
CAH's EV-to-EBIT is ranked higher than
79% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.67 vs. CAH: 16.44 )
CAH' s 10-Year EV-to-EBIT Range
Min: 5.6   Max: 25.5
Current: 16.44

5.6
25.5
PEG 3.96
CAH's PEG is ranked higher than
77% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.00 vs. CAH: 3.96 )
CAH' s 10-Year PEG Range
Min: 0.51   Max: 101
Current: 3.96

0.51
101
Shiller P/E 32.90
CAH's Shiller P/E is ranked higher than
79% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.02 vs. CAH: 32.90 )
CAH' s 10-Year Shiller P/E Range
Min: 5.95   Max: 33.19
Current: 32.9

5.95
33.19
Current Ratio 1.18
CAH's Current Ratio is ranked higher than
52% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. CAH: 1.18 )
CAH' s 10-Year Current Ratio Range
Min: 1.18   Max: 1.83
Current: 1.18

1.18
1.83
Quick Ratio 0.64
CAH's Quick Ratio is ranked lower than
57% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.03 vs. CAH: 0.64 )
CAH' s 10-Year Quick Ratio Range
Min: 0.53   Max: 1.15
Current: 0.64

0.53
1.15
Days Inventory 34.82
CAH's Days Inventory is ranked higher than
82% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 52.56 vs. CAH: 34.82 )
CAH' s 10-Year Days Inventory Range
Min: 25.37   Max: 52.89
Current: 34.82

25.37
52.89
Days Sales Outstanding 21.97
CAH's Days Sales Outstanding is ranked higher than
92% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 56.12 vs. CAH: 21.97 )
CAH' s 10-Year Days Sales Outstanding Range
Min: 13.34   Max: 24.87
Current: 21.97

13.34
24.87

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.50
CAH's Dividend Yield is ranked lower than
63% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.69 vs. CAH: 1.50 )
CAH' s 10-Year Dividend Yield Range
Min: 0.22   Max: 2.66
Current: 1.5

0.22
2.66
Dividend Payout 0.41
CAH's Dividend Payout is ranked higher than
67% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.72 vs. CAH: 0.41 )
CAH' s 10-Year Dividend Payout Range
Min: 0.03   Max: 1.8
Current: 0.41

0.03
1.8
Dividend growth (3y) 16.00
CAH's Dividend growth (3y) is ranked higher than
79% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.90 vs. CAH: 16.00 )
CAH' s 10-Year Dividend growth (3y) Range
Min: 10.8   Max: 49.4
Current: 16

10.8
49.4
Yield on cost (5-Year) 3.22
CAH's Yield on cost (5-Year) is ranked higher than
50% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.04 vs. CAH: 3.22 )
CAH' s 10-Year Yield on cost (5-Year) Range
Min: 0.47   Max: 5.71
Current: 3.22

0.47
5.71
Share Buyback Rate 0.80
CAH's Share Buyback Rate is ranked higher than
82% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.20 vs. CAH: 0.80 )
CAH' s 10-Year Share Buyback Rate Range
Min: 5.8   Max: -22.9
Current: 0.8

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 130.81
CAH's Price/Tangible Book is ranked higher than
56% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.37 vs. CAH: 130.81 )
CAH' s 10-Year Price/Tangible Book Range
Min: 1.21   Max: 118.72
Current: 130.81

1.21
118.72
Price/DCF (Projected) 1.58
CAH's Price/DCF (Projected) is ranked higher than
79% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.74 vs. CAH: 1.58 )
CAH' s 10-Year Price/DCF (Projected) Range
Min: 0.31   Max: 5.4
Current: 1.58

0.31
5.4
Price/Median PS Value 1.98
CAH's Price/Median PS Value is ranked higher than
56% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.33 vs. CAH: 1.98 )
CAH' s 10-Year Price/Median PS Value Range
Min: 0.49   Max: 3.92
Current: 1.98

0.49
3.92
Price/Graham Number 10.39
CAH's Price/Graham Number is ranked higher than
63% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.64 vs. CAH: 10.39 )
CAH' s 10-Year Price/Graham Number Range
Min: 0.75   Max: 9.2
Current: 10.39

0.75
9.2
Earnings Yield (Greenblatt) 6.20
CAH's Earnings Yield (Greenblatt) is ranked higher than
79% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. CAH: 6.20 )
CAH' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.9   Max: 17.9
Current: 6.2

3.9
17.9
Forward Rate of Return (Yacktman) 8.74
CAH's Forward Rate of Return (Yacktman) is ranked higher than
60% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.50 vs. CAH: 8.74 )
CAH' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.9   Max: 25.4
Current: 8.74

3.9
25.4

Analyst Estimate

Jun15 Jun16 Jun17
Revenue(Mil) 97,050 102,130 108,619
EPS($) 4.32 4.82 5.41
EPS without NRI($) 4.32 4.82 5.41

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, SHTDF, HSIC, PDCO » details
Traded in other countries:CLH.Germany,
Cardinal Health Inc is an Ohio corporation formed in 1979. The Company along with its subsidiaries is a healthcare services company providing pharmaceutical and medical products and services that help pharmacies, hospitals and other healthcare providers focus on patient care. The Company also provides medical products to patients in the home. The Company operates in two segments; Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers (including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers), hospitals and other healthcare providers. This segment renders services to pharmaceutical manufacturers including distribution, inventory management, data reporting, and new product launch support; provides pharmacy services to hospitals and other healthcare facilities; and franchises retail pharmacies under the Medicine Shoppe and Medicap brands. It also operates nuclear pharmacies and cyclotron facilities through its Nuclear Pharmacy Services division that manufacture, prepare and deliver radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and physician offices; and distributes specialty pharmaceutical products, provides services to pharmaceutical manufacturers, third-party payors and healthcare providers supporting the development, marketing, distribution and payment for specialty pharmaceutical products, and operates specialty pharmacies through its Specialty Solutions division. The Medical segment distributes a broad range of medical, surgical and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers in the United States, Canada and China and to patients in the home in the United States through its Cardinal Health at Home division. It also manufactures sources and develops its line of private brand medical and surgical products. Manufactured products include: single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems. The Medical segment also assembles and offers sterile and non-sterile procedure kits. Its manufactured products are sold directly or through third-party distributors in the United States, Canada, Europe and other regions internationally. In addition, the segment provides supply chain services, including spend management, distribution management and inventory management services, to healthcare providers. The Company's Pharmaceutical segment competes with wholesale distributors with national reach including McKesson Corporation and AmerisourceBergen Corporation, regional wholesale distributors, self-warehousing chains, specialty distributors, third-party logistics companies, companies that provide services supporting the development, marketing, distributio
» More Articles for CAH

Headlines

Articles On GuruFocus.com
Johnson & Johnson Has A Potential Buyer For Its Medical Devices Unit Feb 24 2015 
Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
Dividend Aristocrats In Focus Part 26 of 54: Walgreens Oct 23 2014 
Dividend Aristocrats In Focus Part 20 of 54: Cardinal Health Oct 16 2014 
AmerisourceBergen Is a Center Piece in the Pharma Industry Sep 30 2014 
Top Insider Sells Highlight: Cardinal Health Inc. Jul 17 2014 
Cardinal Health Inc. (CAH) Dividend Stock Analysis Jul 03 2014 
8 Dividend Stocks with a 15% Yield in 15 Years May 14 2014 
7 Stocks Building Shareholder Returns with Higher Dividends May 12 2014 

More From Our Partners
STAAR Surgical Reports Loss in Q4, Appoints New CEO - Analyst Blog Mar 5 2015 - ZACKS

More From Other Websites
The Morning Ledger: Why CFOs Should Look Past Numbers to Evaluate a Deal Mar 06 2015
Cardinal Health CFO: Deal Making Isn't Just About Numbers Mar 06 2015
Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE Mar 05 2015
Credit Suisse: 8 Biotech and Health Care Stocks Add to Your Portfolio Right Now Mar 05 2015
Cardinal Health Set to Buy Cordis, Shares Hit 52-Week High - Analyst Blog Mar 03 2015
Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE Mar 03 2015
Nasdaq Composite Ends Above 5000 for First Time Since Dot-Com Era Mar 03 2015
Cramer: Market headed for froth-time to sell? Mar 02 2015
Cramer: Market optimistic Mar 02 2015
US STOCKS-Wall St. rallies; Nasdaq hits highest level since 2000 Mar 02 2015
US STOCKS-Wall St. rallies; Nasdaq hits highest level since 2000 Mar 02 2015
Cardinal Health, Inc. -- Moody's: Cardinal Health's planned acquisition of Cordis boosts its lower... Mar 02 2015
US STOCKS-U.S. stocks rally; Nasdaq hits highest level since 2000 Mar 02 2015
US STOCKS-U.S. stocks rally; Nasdaq hits highest level since 2000 Mar 02 2015
US STOCKS-Wall St advances after data and deals; Nasdaq hits 5,000 Mar 02 2015
US STOCKS-Wall St advances after data and deals; Nasdaq hits 5,000 Mar 02 2015
Cardinal to Buy J&J's Heart Business Mar 02 2015
Why Cardinal Health Decided to Buy J&J’s Cordis Unit Mar 02 2015
US STOCKS-Wall St advances, with Nasdaq hitting 5,000, after data Mar 02 2015
US STOCKS-Wall St advances, with Nasdaq hitting 5,000, after data Mar 02 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK